Screening Services

Illuminating your next big discovery with our collection of assay services

At ION Biosciences, we specialize in the early stages of integrated drug discovery, including hit identification, hit validation, and hit-to-lead optimization, as part of our screening services portfolio. Our expertise in developing and manufacturing fluorescence-based assay technologies, combined with advanced instrumentation for even the most complex of protocols, enable high-speed, reliable data capture to accelerate your discovery journey. 

We manufacture a large collection of fluorescent ion indicators and ready-to-use assay kits for discovering modulators of a large range of druggable targets, including ion channels, transporters, and GPCRs. Among these are a suite of proprietary assay technologies, including:

These innovative assays showcase our commitment to advancing drug discovery and developing solutions that provide relevant, actionable insights for your pipeline. All of our assays were developed by the same experts that will support your screening service needs. Our team is supported by advanced instrumentation that can make even the most challenging of assays, routine. Led by the Panoptic from WaveFront Biosciences, a powerful fluorescence imaging plate reader (FLIPR) that is built on top of an Agilent Bravo liquid handler, that can accommodate 96-384 well plates and fluorescence or luminescence read modes. Panoptic is equipped with:

We also have a Cytation 5, multimode plate reader and fluorescence imager, and Flexstation III, a lower throughput kinetic plate reader, to meet your assay needs.

Whether you need a single high-throughput screening assay developed, recurring screening services, or a fully integrated solution, our team provides expert guidance, competitive pricing, and fast turnaround times to support your next breakthrough. Partner with us to discover a brighter future—contact our experts today.